YB1-rt-PA
N/A
Report date: 2023/10/25 11:48:11
Base Information
Drug NameYB1-rt-PA
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesThe University Of Hong Kong
China Registration ClassN/A
Develop Information
Active CompaniesHknd YB1 Pharmaceutical Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A